9-02-2023, 21:11

Prelude Therapeutics To Participate in Two Upcoming

WILMINGTON, Del., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a
Globe Newswire9-02-2023, 21:11
7-02-2023, 04:32

Arvinas to Participate in Upcoming Investor Conferences

NEW HAVEN, Conn., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology
Globe Newswire7-02-2023, 04:32